Future research should further elucidate the specific mechanisms of ANGPTL4 and CFD in breast cancer and develop clinical detection methods and treatment strategies based on these biomarkers, thereby advancing precision medicine in breast cancer. This evidence concerns the gene CFD and breast cancer.